Email updates

Keep up to date with the latest news and content from BMC Proceedings and BioMed Central.

This article is part of the supplement: Proceedings of the International Symposium on Animal Genomics for Animal Health (AGAH 2010)

Open Access Proceedings

Porcine type I interferons: polymorphic sequences and activity against PRRSV

Yongming Sang1, Raymond RR Rowland2 and Frank Blecha1*

Author Affiliations

1 Department of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, Kansas, USA

2 Department of Diagnostic Medicine and Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, Kansas, USA

For all author emails, please log on.

BMC Proceedings 2011, 5(Suppl 4):S8  doi:10.1186/1753-6561-5-S4-S8

The electronic version of this article is the complete one and can be found online at: http://www.biomedcentral.com/1753-6561/5/S4/S8


Published:3 June 2011

© 2011 Sang et al; licensee BioMed Central Ltd.

This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

Type I interferons (IFN) are a heterogeneous group of cytokines central to innate and adaptive antiviral immune responses. We have recently reported that porcine type I IFNs comprise at least 39 functional genes with diverse antiviral activity against porcine reproductive and respiratory syndrome virus (PRRSV). Here we report that potential cytokine polymorphisms exist in several genes of porcine type I IFNs.

Results

We have detected more than 100 potential polymorphic mutations, which include nucleotide substitutions and deletions, within the coding regions of porcine type I IFNs. Approximately 50% of the nucleotide changes were mutations that resulted in non-conserved amino acid substitution, as well as deletions that produced frame shifts in the open reading frames (ORFs). We have identified more than 20 polymorphic mutants that showed alterations in anti-PRRSV and anti-vesicular stomatitis virus (VSV) activity in vitro. In particular, some mutations in IFN-α2, IFN-α3, IFN-α8, IFN-α12 and IFN-ω5 significantly altered the antiviral activity of expressed proteins in comparison to the wild-type or variant with more similarity to the wild-type.

Conclusions

Multiple polymorphic isoforms potentially exist within subtypes of the porcine type I IFN family. Polymorphic mutations are more common in multiple-member subtypes than single-member subtypes, and most are found within the IFN-α subclass. Some polymorphic isoforms have altered amino acid composition and shifted ORFs, which show significantly different antiviral activity in vitro.

Background

Type I interferons (IFNs) are a family of cytokines prominent in antiviral responses [1,2]. Genetic mutations that result in dysfunction of type I IFN production and actions are ultimately associated with susceptibility to viral diseases [2,3]. Conversely, viruses may antagonize or evade type I IFN actions resulting in successful infections [4]. In this context, porcine reproductive and respiratory syndrome virus (PRRSV), a RNA virus that causes devastating losses in the global swine industry, suppresses type I IFN production [5,6]; and diverse PRRSV strains manifest different abilities to suppress type I IFN expression [7]. Furthermore, emerging evidence implicates that cytokine polymorphisms such as those in IFN-γ and interleukin (IL)-8 are key factors in breed- or genotype-associated viral resistance [8-10]. However, how type I IFN polymorphisms affect resistance to PRRSV infection is not known. We have recently reported that the porcine type I IFN family consists of at least 39 functional genes, which are classified into seven subclasses of 17 IFN-α, 11 IFN-δ, and 7 IFN-ω subtypes, and single-subtype subclasses consisting of IFN-αω, IFN-β, IFN-ε, and IFN-κ [11]. We showed that members of different or the same porcine type I IFN subclasses have diverse expression profiles in various pig tissues and in vitro antiviral activities [11]. Here we report that expressed proteins from multiple polymorphic isoforms within subtypes of type I IFNs have significantly altered antiviral activity, which may represent an important factor for determining the outcome of the host-virus interaction.

Methods

The isolation and analyses of IFN genes were conducted as previously described [11]. In brief, coding regions of porcine IFNs were amplified from several cDNA and genomic DNA pools using a high-fidelity PCR with subtype-common cloning primers. PCR fragments, which flank six nucleotides before the start codon and stop codon of each IFN ORF, were purified and cloned into a pcDNA™ 3.3-TOPO® TA cloning/expression vector (Invitrogen, Carlsbad, CA) under the action of the vector CVM promoter. At least five clones for each IFN gene were sequenced and clones that showed the highest sequence identity (>97%) to the reference sequences (extracted from genomic draft sequences by Sanger Institute Porcine Project Team, which is available from http://www.ensembl.org/Sus_scrofa/index.html webcite) were selected as polymorphic variants of a particular IFN for mutation definition and protein expression. Mutation determination was conducted by combined use of sequence analysis tools in Lasergene v8.1 (DNASTAR, Inc. Madison, WI) and Bioedit (http://www.mbio.ncsu.edu/BioEdit/bioedit.html webcite). IFN peptides were collected and partially purified from supernatants of HEK293F cells transfected with individual IFN-expression plasmids. Authentic expression of individual IFN peptides was confirmed by gel electrophoresis; and peptide concentrations were adjusted to 2 μg/ml with the serum-free medium to ensure the antiviral differences were not a result of peptide levels in the antiviral assays (11). Antiviral activity of overexpressed IFN peptides was assayed as the inhibition of the cytopathic effect (CPE) of PRRSV and VSV on MARC-145 and PK-15 cells, respectively, in which 1 unit is defined as the highest dilution that reduced cell loss by 50% according to the Reed-Muench method [11].

Results and conclusions

Existence of multiple polymorphic isoforms in IFN-α, IFN-δ and IFN-ω subtypes

Summarized in Table 1 are 18 polymorphic isoforms that have non-conservative amino acid changes and potentially show altered antiviral activity. Indeed, single nucleotide polymorphisms (SNP) have been found in most porcine IFN subtypes, in particular in IFN-α, IFN-ω and IFN-δ subclasses, which consist of multiple subtypes. Among all SNPs, approximately 50% cause changes at the amino acid level, including non-conservative substitution of certain residues and deletions resulting in frame shift of translation. The SNP sites are detected along all regions including signal peptides and the five helical regions but are concentrated within the middle region of 40-150 amino acid residues.

Table 1. Polymorphic isoforms of porcine type I interferons (IFNs)

Diverse activity of polymorphic type I IFNs

Using IFN polypeptides expressed in a mammalian cell system [11], eight polymorphic IFNs showed altered antiviral activity against both PRRSV and VSV in vitro considering the different effects of cytopathic inhibition with the same amount of peptides. In comparison to the wild-type or the variant with more similarity to the wild-type, residual substitution of Leu40-Phe and Cys109-Arg in IFN-α2-1, Lys145-Glu in IFN-α3-1, deletion of Arg46 in IFN-α8μ, Phe88-Ser in IFN-α10-1, and Cys52-Arg in IFN-ω5-1, dramatically reduced antiviral activity against both PRRSV and VSV. The mutations had a more profound effect on reducing anti-PRRSV activity in MARC-145 cells than anti-VSV activity in PK-15 cells (Fig. 1). In addition, deletion mutants, such as IFN-α8μ and IFN-α12μ which are more atypical in their peptide sequence, showed little antiviral activity in both virus-cell systems. Because polymorphism among porcine type I IFN genes may represent an important factor for determining the outcome of the host-virus interaction, it will be informative to correlate IFN polymorphism in pigs with susceptibility to PRRSV and severity of PRRSV infection.

thumbnailFigure 1. Differential antiviral activity among polymorphic isoforms of some subtypes of porcine type I IFNs. Antiviral activity against PRRSV and VSV was evaluated as described in Sang et al., 2010 [11], and analyzed based on individual polymorphic isoforms. Authentic expression of individual IFN peptides was confirmed by gel electrophoresis. Peptide concentrations were adjusted to 2 μg/ml to ensure the antiviral differences were not a result of peptide levels in the antiviral assays. Antiviral activity of overexpressed IFN peptides was assayed as the inhibition of virus cytopathic effect, in which 1 unit (U) is defined as the highest dilution that reduced cell loss by 50% according to the Reed-Muench method. Data are means from four duplicates of two independent experiments. *p<0.05, n=4.

Competing interests

The authors declare no competing interests related to this manuscript.

Acknowledgements

This work was supported in part by USDA NRICGP grants 2003-35204-13704 and 2006-35204-17337. We thank Danielle Goodband for her excellent technical support.

This article has been published as part of BMC Proceedings Volume 5 Supplement 4, 2011: Proceedings of the International Symposium on Animal Genomics for Animal Health (AGAH 2010). The full contents of the supplement are available online at http://www.biomedcentral.com/1753-6561/5?issue=S4.

References

  1. Le Bon A, Tough DF: Type I interferon as a stimulus for cross-priming.

    Cytokine Growth Factor Rev. 2008, 19:33-40. PubMed Abstract | Publisher Full Text OpenURL

  2. Kohlmeier JE, Woodland DL: Immunity to respiratory viruses.

    Annu Rev Immunol. 2009, 27:61-82. PubMed Abstract | Publisher Full Text OpenURL

  3. Pichlmair A, Reis e Sousa C: Innate recognition of viruses.

    Immunity 2007, 27:370-383. PubMed Abstract | Publisher Full Text OpenURL

  4. Weber F, Haller O: Viral suppression of the interferon system.

    Biochimie. 2007, 89:836-842. PubMed Abstract | Publisher Full Text OpenURL

  5. Neumann EJ, Kliebenstein JB, Johnson CD, Mabry JW, Bush EJ, Seitzinger AH, Green AL, Zimmerman JJ: Assessment of the economic impact of porcine reproductive and respiratory syndrome on swine production in the United States.

    J Am Vet Med Assoc. 2005, 227:385-392. PubMed Abstract | Publisher Full Text OpenURL

  6. Beura LK, Sarkar SN, Kwon B, Subramaniam S, Jones C, Pattnaik AK, Osorio FA: Porcine reproductive and respiratory syndrome virus nonstructural protein 1beta modulates host innate immune response by antagonizing IRF3 activation.

    J Virol. 2010, 84:1574-1584. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  7. Lee SM, Schommer SK, Kleiboeker SB: Porcine reproductive and respiratory syndrome virus field isolates differ in in vitro interferon phenotypes.

    Vet Immunol Immunopathol. 2004, 102:217-231. PubMed Abstract | Publisher Full Text OpenURL

  8. Lunney JK, Fritz ER, Reecy JM, Kuhar D, Prucnal E, Molina R, Christopher-Hennings J, Zimmerman J, Rowland RR: Interleukin-8, interleukin-1beta, and interferon-gamma levels are linked to PRRS virus clearance.

    Viral Immunol. 2010, 23:127-134. PubMed Abstract | Publisher Full Text OpenURL

  9. Christopher-Hennings J, Holler LD, Benfield DA, Nelson EA: Detection and duration of porcine reproductive and respiratory syndrome virus in semen, serum, peripheral blood mononuclear cells, and tissues from Yorkshire, Hampshire, and Landrace boars.

    J. Vet. Diagn. Invest 2001, 13:133-142. PubMed Abstract | Publisher Full Text OpenURL

  10. Jafer O, Zhang S, Sargent C, Mellencamp MA, Evans G, Mileham A, Plastow G, Affara N: Identification of SNPs in porcine genes expressed during porcine respiratory and reproductive syndrome virus infection.

    Anim Genet. 2009, 40:580-582. PubMed Abstract | Publisher Full Text OpenURL

  11. Sang Y, Rowland RR, Hesse RA, Blecha F: Differential expression and activity of the porcine type I interferon family.

    Physiol Genomics. 2010, 42:248-258. PubMed Abstract | Publisher Full Text OpenURL